The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases

Frontiers in Neuroscience

Volumn 8, Issue DEC, 2014, Pages

  Al Mahdawi, Sahar ^a   Virmouni, Sara Anjomani ^a   Pook, Mark A ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

5 hydroxymethylcytosine; Alzheimer's disease; Amyotrophic lateral sclerosis; Fragile X associated tremor ataxia syndrome; Friedreich ataxia; Huntington's disease; Parkinson's disease

Indexed keywords

5 HYDROXYMETHYLCYTOSINE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM; CHROMATIN; COGNITION; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DNA MODIFICATION; ENVIRONMENTAL STRESS; ENZYME ACTIVITY; EPIGENETICS; FRAGILE X ASSOCIATED TREMOR ATAXIA SYNDROME; FRAGILE X SYNDROME; FRIEDREICH ATAXIA; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTONE DEMETHYLATION; HUMAN; HUNTINGTON CHOREA; NERVE CELL DIFFERENTIATION; NONHUMAN; OXIDATION; PARKINSON DISEASE; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; REGULATOR GENE; REVIEW; TRANSLOCATION LINE; TREMOR;

EID: 84920573510     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00397     Document Type: Review

References (92)

1. Ahmed, A., and Wicklund, M. P. (2011). Amyotrophic lateral sclerosis: what role does environment play? Neurol. Clin. 29, 689-711. doi: 10.1016/j.ncl.2011.06.001
2. Al-Mahdawi, S., Pinto, R. M., Ismail, O., Varshney, D., Lymperi, S., Sandi, C., et al. (2008). The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues. Hum. Mol. Genet. 17, 735-746. doi: 10.1093/hmg/ddm346
3. Al-Mahdawi, S., Sandi, C., Mouro Pinto, R., and Pook, M. A. (2013). Friedreich ataxia patient tissues exhibit increased 5-hydroxymethylcytosine modification and decreased CTCF binding at the FXN locus. PLoS ONE 8:e74956. doi: 10.1371/journal.pone.0074956
4. Amir, R. E., Van den Veyver, I.B., Wan, M., Tran, C. Q., Francke, U., and Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185-188. doi: 10.1038/13810
5. Bagni, C., and Oostra, B. A. (2013). Fragile X syndrome: from protein function to therapy. Am. J. Med. Genet. A 161A, 2809-2821. doi: 10.1002/ajmg.a.36241
6. Barrachina, M., and Ferrer, I. (2009). DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J. Neuropathol. Exp. Neurol. 68, 880-891. doi: 10.1097/NEN.0b013e3181af2e46
7. Bihaqi, S. W., Schumacher, A., Maloney, B., Lahiri, D. K., and Zawia, N. H. (2012). Do epigenetic pathways initiate late onset Alzheimer disease (LOAD): towards a new paradigm. Curr. Alzheimer Res. 9, 574-588. doi: 10.2174/156720512800617982
8. Bird, A. P., and Wolffe, A. P. (1999). Methylation-induced repression-belts, braces, and chromatin. Cell 99, 451-454 doi: 10.1016/S0092-8674(00)81532-9
9. Bostick, M., Kim, J. K., Esteve, P. O., Clark, A., Pradhan, S., and Jacobsen, S. E. (2007). UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 317, 1760-1764. doi: 10.1126/science.1147939
10. Bradley-Whitman, M. A., and Lovell, M. A. (2013). Epigenetic changes in the progression of Alzheimer's disease. Mech. Ageing Dev. 134, 486-495. doi: 10.1016/j.mad.2013.08.005
11. Branco, M. R., Ficz, G., and Reik, W. (2011). Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat. Rev. Genet. 13, 7-13. doi: 10.1038/nrg3080
12. Calvo, A. C., Manzano, R., Mendonca, D. M., Munoz, M. J., Zaragoza, P., and Osta, R. (2014). Amyotrophic lateral sclerosis: a focus on disease progression. Biomed Res. Int. 2014:925101. doi: 10.1155/2014/925101
13. Campuzano, V., Montermini, L., Molto, M. D., Pianese, L., Cossee, M., Cavalcanti, F., et al. (1996). Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423-1427 doi: 10.1126/science.271.5254.1423
14. Castaldo, I., Pinelli, M., Monticelli, A., Acquaviva, F., Giacchetti, M., Filla, A., et al. (2008). DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients. J. Med. Genet. 45, 808-812. doi: 10.1136/jmg.2008.058594
15. Chen, C. C., Wang, K. Y., and Shen, C. K. (2012). The mammalian de novo DNA methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcytosine dehydroxymethylases. J. Biol. Chem. 287, 33116-33121. doi: 10.1074/jbc. C112.406975
16. Chen, S., Sayana, P., Zhang, X., and Le, W. (2013). Genetics of amyotrophic lateral sclerosis: an update. Mol. Neurodegener. 8:28. doi: 10.1186/1750-1326-8-28
17. Chen, Y., Damayanti, N. P., Irudayaraj, J., Dunn, K., and Zhou, F. C. (2014). Diversity of two forms of DNA methylation in the brain. Front. Genet. 5:46. doi: 10.3389/fgene.2014.00046
18. Cheng, Y., Bernstein, A., Chen, D., and Jin, P. (2014). 5-Hydroxymethylcytosine: a new player in brain disorders? Exp. Neurol. doi: 10.1016/j.expneurol.2014.05.008. [Epub ahead of print].
19. Chia, N., Wang, L., Lu, X., Senut, M. C., Brenner, C., and Ruden, D. M. (2011). Hypothesis: environmental regulation of 5-hydroxymethylcytosine by oxidative stress. Epigenetics 6, 853-856. doi: 10.4161/epi.6.7.16461
20. Chouliaras, L., Mastroeni, D., Delvaux, E., Grover, A., Kenis, G., Hof, P. R., et al. (2013). Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol. Aging 34, 2091-2099. doi: 10.1016/j.neurobiolaging.2013.02.021
21. Cnop, M., Mulder, H., and Igoillo-Esteve, M. (2013). Diabetes in Friedreich ataxia. J. Neurochem. 126(Suppl. 1), 94-102. doi: 10.1111/jnc.12216
22. Coppieters, N., Dieriks, B. V., Lill, C., Faull, R. L., Curtis, M. A., and Dragunow, M. (2014). Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain. Neurobiol. Aging 35, 1334-1344. doi: 10.1016/j.neurobiolaging.2013.11.031
23. Coppieters, N., and Dragunow, M. (2011). Epigenetics in Alzheimer's disease: a focus on DNA modifications. Curr. Pharm. Des. 17, 3398-3412. doi: 10.2174/138161211798072544
24. Cortellino, S., Xu, J., Sannai, M., Moore, R., Caretti, E., Cigliano, A., et al. (2011). Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 146, 67-79. doi: 10.1016/j.cell.2011.06.020
25. Evans-Galea, M. V., Carrodus, N., Rowley, S. M., Corben, L. A., Tai, G., Saffery, R., et al. (2012). FXN methylation predicts expression and clinical outcome in Friedreich ataxia. Ann. Neurol. 71, 487-497. doi: 10.1002/ana.22671
26. Evans-Galea, M. V., Hannan, A. J., Carrodus, N., Delatycki, M. B., and Saffery, R. (2013). Epigenetic modifications in trinucleotide repeat diseases. Trends Mol. Med. 19, 655-663. doi: 10.1016/j.molmed.2013.07.007
27. Ficz, G., Branco, M. R., Seisenberger, S., Santos, F., Krueger, F., Hore, T. A., et al. (2011). Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473, 398-402. doi: 10.1038/nature10008
28. Figueroa-Romero, C., Hur, J., Bender, D. E., Delaney, C. E., Cataldo, M. D., Smith, A. L., et al. (2012). Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS ONE 7:e52672. doi: 10.1371/journal.pone.0052672
29. Frauer, C., Hoffmann, T., Bultmann, S., Casa, V., Cardoso, M. C., Antes, I., et al. (2011). Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA domain. PLoS ONE 6:e21306. doi: 10.1371/journal.pone.0021306
30. Glass, M., Dragunow, M., and Faull, R. L. (2000). The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience 97, 505-519. doi: 10.1016/S0306-4522(00)00008-7
31. Globisch, D., Munzel, M., Muller, M., Michalakis, S., Wagner, M., Koch, S., et al. (2010). Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS ONE 5:e15367. doi: 10.1371/journal.pone.0015367
32. Greene, E., Mahishi, L., Entezam, A., Kumari, D., and Usdin, K. (2007). Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia. Nucleic Acids Res. 35, 3383-3390. doi: 10.1093/nar/gkm271
33. Gu, T. P., Guo, F., Yang, H., Wu, H. P., Xu, G. F., Liu, W., et al. (2011). The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477, 606-610. doi: 10.1038/nature10443
34. Guo, J. U., Su, Y., Zhong, C., Ming, G. L., and Song, H. (2011). Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145, 423-434. doi: 10.1016/j.cell.2011.03.022
35. Haffner, M. C., Pellakuru, L. G., Ghosh, S., Lotan, T. L., Nelson, W. G., De Marzo, A. M., et al. (2013). Tight correlation of 5-hydroxymethylcytosine and Polycomb marks in health and disease. Cell Cycle 12, 1835-1841. doi: 10.4161/cc.25010
36. Hagerman, R. J., Leehey, M., Heinrichs, W., Tassone, F., Wilson, R., Hills, J., et al. (2001). Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57, 127-130 doi: 10.1212/WNL.57.1.127
37. Hashem, V., Galloway, J. N., Mori, M., Willemsen, R., Oostra, B. A., Paylor, R., et al. (2009). Ectopic expression of CGG containing mRNA is neurotoxic in mammals. Hum. Mol. Genet. 18, 2443-2451. doi: 10.1093/hmg/ddp182
38. He, Y. F., Li, B. Z., Li, Z., Liu, P., Wang, Y., Tang, Q., et al. (2011). Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303-1307. doi: 10.1126/science.1210944
39. Iacobazzi, V., Castegna, A., Infantino, V., and Andria, G. (2013). Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol. Genet. Metab. 110, 25-34. doi: 10.1016/j.ymgme.2013.07.012
40. Inoue, A., and Zhang, Y. (2011). Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science 334, 194. doi: 10.1126/science.1212483
41. Ito, S., D'Alessio, A. C., Taranova, O. V., Hong, K., Sowers, L. C., and Zhang, Y. (2010). Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466, 1129-1133. doi: 10.1038/nature09303
42. Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., et al. (2011). Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300-1303. doi: 10.1126/science.1210597
43. Jacquemont, S., Hagerman, R. J., Leehey, M., Grigsby, J., Zhang, L., Brunberg, J. A., et al. (2003). Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am. J. Hum. Genet. 72, 869-878. doi: 10.1086/374321
44. Jin, C., Lu, Y., Jelinek, J., Liang, S., Estecio, M. R., Barton, M. C., et al. (2014). TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cells. Nucleic Acids Res. 42, 6956-6971. doi: 10.1093/nar/gku372
45. Jin, P., Zarnescu, D. C., Zhang, F., Pearson, C. E., Lucchesi, J. C., Moses, K., et al. (2003). RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39, 739-747. doi: 10.1016/S0896-6273(03)00533-6
46. Khare, T., Pai, S., Koncevicius, K., Pal, M., Kriukiene, E., Liutkeviciute, Z., et al. (2012). 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary. Nat. Struct. Mol. Biol. 19, 1037-1043. doi: 10.1038/nsmb.2372
47. Koeppen, A. H. (2013). Nikolaus Friedreich and degenerative atrophy of the dorsal columns of the spinal cord. J. Neurochem. 126(Suppl. 1), 4. doi: 10.1111/jnc.12218
48. Kohli, R. M., and Zhang, Y. (2013). TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502, 472-479. doi: 10.1038/nature12750
49. Kriaucionis, S., and Heintz, N. (2009). The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929-930. doi: 10.1126/science.1169786
50. Kulis, M., and Esteller, M. (2010). DNA methylation and cancer. Adv. Genet. 70, 27-56. doi: 10.1016/B978-0-12-380866-0.60002-2
51. Landles, C., and Bates, G. P. (2004). Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep. 5, 958-963. doi: 10.1038/sj.embor.7400250
52. Lu, H., Liu, X., Deng, Y., and Qing, H. (2013). DNA methylation, a hand behind neurodegenerative diseases. Front. Aging Neurosci. 5:85. doi: 10.3389/fnagi.2013.00085
53. MacDonald, M. E., Gines, S., Gusella, J. F., and Wheeler, V. C. (2003). Huntington's disease. Neuromolecular Med. 4, 7-20. doi: 10.1385/NMM:4:1-2:7
54. Maiti, A., and Drohat, A. C. (2011). Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J. Biol. Chem. 286, 35334-35338. doi: 10.1074/jbc. C111.284620
55. Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C., Coleman, P. D., and Rogers, J. (2010). Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol. Aging 31, 2025-2037. doi: 10.1016/j.neurobiolaging.2008.12.005
56. Mellen, M., Ayata, P., Dewell, S., Kriaucionis, S., and Heintz, N. (2012). MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417-1430. doi: 10.1016/j.cell.2012.11.022
57. Nakamura, T., Liu, Y. J., Nakashima, H., Umehara, H., Inoue, K., Matoba, S., et al. (2012). PGC7 binds histone H3K9me2 to protect against conversion of 5mC to 5hmC in early embryos. Nature 486, 415-419. doi: 10.1038/nature11093
58. Naumann, A., Hochstein, N., Weber, S., Fanning, E., and Doerfler, W. (2009). A distinct DNA-methylation boundary in the 5'- upstream sequence of the FMR1 promoter binds nuclear proteins and is lost in fragile X syndrome. Am. J. Hum. Genet. 85, 606-616. doi: 10.1016/j.ajhg.2009.09.018
59. Pastor, W. A., Pape, U. J., Huang, Y., Henderson, H. R., Lister, R., Ko, M., et al. (2011). Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473, 394-397. doi: 10.1038/nature10102
60. Pfeifer, G. P., Kadam, S., and Jin, S. G. (2013). 5-hydroxymethylcytosine and its potential roles in development and cancer. Epigenetics Chromatin. 6:10. doi: 10.1186/1756-8935-6-10
61. Pook, M. A. (2012). "DNA methylation and trinucleotide repeat expansion diseases," in DNA Methylation - From Genomics to Technology, ed T. Tatarinova (InTech.). doi: 10.5772/34169
62. Raiber, E. A., Beraldi, D., Ficz, G., Burgess, H. E., Branco, M. R., Murat, P., et al. (2012). Genome-wide distribution of 5-formylcytosine in embryonic stem cells is associated with transcription and depends on thymine DNA glycosylase. Genome Biol. 13:R69. doi: 10.1186/gb-2012-13-8-r69
63. Rao, J. S., Keleshian, V. L., Klein, S., and Rapoport, S. I. (2012). Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients. Transl. Psychiatry 2, e132. doi: 10.1038/tp.2012.55
64. Robertson, K. D. (2001). DNA methylation, methyltransferases, and cancer. Oncogene 20, 3139-3155. doi: 10.1038/sj.onc.1204341
65. Rogaev, E. I., Lukiw, W. J., Lavrushina, O., Rogaeva, E. A., and St. George-Hyslop, P. H. (1994). The upstream promoter of the beta-amyloid precursor protein gene (APP) shows differential patterns of methylation in human brain. Genomics 22, 340-347. doi: 10.1006/geno.1994.1393
66. Sandi, C., Sandi, M., Anjomani Virmouni, S., Al-Mahdawi, S., and Pook, M. A. (2014). Epigenetic-based therapies for Friedreich ataxia. Front. Genet. 5:165. doi: 10.3389/fgene.2014.00165
67. Sathasivam, K., Neueder, A., Gipson, T. A., Landles, C., Benjamin, A. C., Bondulich, M. K., et al. (2013). Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc. Natl. Acad. Sci. U.S.A. 110, 2366-2370. doi: 10.1073/pnas.1221891110
68. Song, C. X., Clark, T. A., Lu, X. Y., Kislyuk, A., Dai, Q., Turner, S. W., et al. (2011a). Sensitive and specific single-molecule sequencing of 5-hydroxymethylcytosine. Nat. Methods 9, 75-77. doi: 10.1038/nmeth.1779
69. Song, C. X., Szulwach, K. E., Fu, Y., Dai, Q., Yi, C., Li, X., et al. (2011b). Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 29, 68-72. doi: 10.1038/nbt.1732
70. Spruijt, C. G., Gnerlich, F., Smits, A. H., Pfaffeneder, T., Jansen, P. W., Bauer, C., et al. (2013). Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 152, 1146-1159. doi: 10.1016/j.cell.2013.02.004
71. Stewart, S. K., Morris, T. J., Guilhamon, P., Bulstrode, H., Bachman, M., Balasubramanian, S., et al. (2014). oxBS-450K: a method for analysing hydroxymethylation using 450K BeadChips. Methods. doi: 10.1016/j.ymeth.2014.08.009. [Epub ahead of print].
72. Stroud, H., Feng, S., Morey Kinney, S., Pradhan, S., and Jacobsen, S. E. (2011). 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol. 12:R54. doi: 10.1186/gb-2011-12-6-r54
73. Szulwach, K. E., Li, X., Li, Y., Song, C. X., Han, J. W., Kim, S., et al. (2011a). Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet. 7:e1002154. doi: 10.1371/journal.pgen.1002154
74. Szulwach, K. E., Li, X., Li, Y., Song, C. X., Wu, H., Dai, Q., et al. (2011b). 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat. Neurosci. 14, 1607-1616. doi: 10.1038/nn.2959
75. Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., et al. (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935. doi: 10.1126/science.1170116
76. Tanzi, R. E. (2012). The genetics of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, 1-10. doi: 10.1101/cshperspect.a006296
77. Tohgi, H., Utsugisawa, K., Nagane, Y., Yoshimura, M., Genda, Y., and Ukitsu, M. (1999). Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex. Brain Res. Mol. Brain Res. 70, 288-292. doi: 10.1016/S0169-328X(99)00163-1
78. Villar-Menendez, I., Blanch, M., Tyebji, S., Pereira-Veiga, T., Albasanz, J. L., Martin, M., et al. (2013). Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease. Neuromolecular Med. 15, 295-309. doi: 10.1007/s12017-013-8219-0
79. Wang, F., Yang, Y., Lin, X., Wang, J. Q., Wu, Y. S., Xie, W., et al. (2013). Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease. Hum. Mol. Genet. 22, 3641-3653. doi: 10.1093/hmg/ddt214
80. Wang, S. C., Oelze, B., and Schumacher, A. (2008). Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS ONE 3:e2698. doi: 10.1371/journal.pone.0002698
81. Wang, T., Pan, Q., Lin, L., Szulwach, K. E., Song, C. X., He, C., et al. (2012). Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum. Hum. Mol. Genet. 21, 5500-5510. doi: 10.1093/hmg/dds394
82. Weidemann, F., Stork, S., Liu, D., Hu, K., Herrmann, S., Ertl, G., et al. (2013). Cardiomyopathy of Friedreich ataxia. J. Neurochem. 126(Suppl. 1), 88-93. doi: 10.1111/jnc.12217
83. Wu, H., D'Alessio, A. C., Ito, S., Wang, Z., Cui, K., Zhao, K., et al. (2011). Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev. 25, 679-684. doi: 10.1101/gad.2036011
84. Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., et al. (2012). Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26, 1326-1338. doi: 10.1101/gad.191056.112
85. Xu, Y., Wu, F., Tan, L., Kong, L., Xiong, L., Deng, J., et al. (2011). Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol. Cell 42, 451-464. doi: 10.1016/j.molcel.2011.04.005
86. Yamaguchi, S., Hong, K., Liu, R., Shen, L., Inoue, A., Diep, D., et al. (2012). Tet1 controls meiosis by regulating meiotic gene expression. Nature 492, 443-447. doi: 10.1038/nature11709
87. Yamaguchi, S., Shen, L., Liu, Y., Sendler, D., and Zhang, Y. (2013). Role of Tet1 in erasure of genomic imprinting. Nature 504, 460-464. doi: 10.1038/nature12805
88. Yang, Y. X., Wood, N. W., and Latchman, D. S. (2009). Molecular basis of Parkinson's disease. Neuroreport 20, 150-156. doi: 10.1097/WNR.0b013e32831c50df
89. Yao, B., Lin, L., Street, R. C., Zalewski, Z. A., Galloway, J. N., Wu, H., et al. (2014). Genome-wide alteration of 5-hydroxymethylcytosine in a mouse model of fragile X-associated tremor/ataxia syndrome. Hum. Mol. Genet. 23, 1095-1107. doi: 10.1093/hmg/ddt504
90. Yildirim, O., Li, R., Hung, J. H., Chen, P. B., Dong, X., Ee, L. S., et al. (2011). Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells. Cell 147, 1498-1510. doi: 10.1016/j.cell.2011.11.054
91. Yin, R., Mao, S. Q., Zhao, B., Chong, Z., Yang, Y., Zhao, C., et al. (2013). Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J. Am. Chem. Soc. 135, 10396-10403. doi: 10.1021/ja4028346
92. Zhang, B., Lv, Q., Pu, J., Lei, X., and Mao, Y. (2013). distribution of 5-hydroxymethylcytosine in rat brain tissues and the role of 5-hydroxymethylcytosine in aging and vivo model of Parkinson's disease. Mov. Disor. 28(Suppl. 1), 852